The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The expression of GATA-3 and FOXA1 in breast cancer: The biomarkers of hormone sensitivity in luminal-type tumors.
Y. Hisamatsu
No relevant relationships to disclose
E. Tokunaga
No relevant relationships to disclose
S. Akiyoshi
No relevant relationships to disclose
S. Okada
No relevant relationships to disclose
N. Yamashita
No relevant relationships to disclose
E. Oki
No relevant relationships to disclose
M. Morita
No relevant relationships to disclose
Y. Kakeji
No relevant relationships to disclose
Y. Maehara
No relevant relationships to disclose